Plasma Proteomics Reveals Dysregulated Pathways Across the Spectrum <i>LMNA</i> Cardiomyopathy
Usman A. Tahir(Beth Israel Deaconess Medical Center), Neal K. Lakdawala(Brigham and Women's Hospital), Jacob L. Barber(Beth Israel Deaconess Medical Center), Laurie Farrell(Beth Israel Deaconess Medical Center), Joshen Patel(Brigham and Women's Hospital), Robert E. Gerszten(Beth Israel Deaconess Medical Center), Gaurav Tiwari(Beth Israel Deaconess Medical Center), Julia E. Marine(Brigham and Women's Hospital), Catherine G. Ireland(Brigham and Women's Hospital), Daniel Reichart(Brigham and Women's Hospital), Anisha Purohit(Brigham and Women's Hospital), Carolyn Y. Ho(Brigham and Women's Hospital), Darius Roy(Brigham and Women's Hospital), Christine E. Seidman(Harvard University)
Cited by 1
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k